Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000986764 | SCV001135880 | pathogenic | Fanconi anemia complementation group A | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001858651 | SCV002239123 | pathogenic | Fanconi anemia | 2023-11-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln99Argfs*17) in the FANCL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCL are known to be pathogenic (PMID: 19405097, 23613520). This variant is present in population databases (rs779544327, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with FANCL-related conditions. ClinVar contains an entry for this variant (Variation ID: 801717). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV002284451 | SCV002574164 | uncertain significance | not provided | 2022-03-13 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge |
Baylor Genetics | RCV003467543 | SCV004197265 | likely pathogenic | Fanconi anemia complementation group L | 2024-03-17 | criteria provided, single submitter | clinical testing |